MedCalcHub stores your favorites, history, and saved calculations locally in your browser using localStorage. This data never leaves your device.
Optional advertising, when enabled, may use third-party cookies or similar technologies. You can accept or reject advertising below.
Calculates the gradient between serum albumin and ascitic fluid albumin to classify ascites as portal hypertensive (SAAG ≥1.1 g/dL) or non-portal hypertensive (SAAG <1.1 g/dL). First-line diagnostic tool for ascites workup.
SAAG = Serum albumin (g/dL) − Ascites albumin (g/dL)
≥1.1 g/dL (portal hypertension)
The SAAG was introduced by Boyer et al. in 1968 and is the single most reliable test for classifying ascites. A SAAG ≥1.1 g/dL correctly identifies portal hypertension with >90% accuracy. It replaces the older transudate/exudate classification, which was unreliable for ascites due to the confounding effect of serum albumin on ascitic fluid protein.
Specialty
Internal MedicineCategory
GastroenterologyDifficulty
Basic
Estimated Time
30 seconds
Version
1.0
Last Updated
2026-08
Formula
Keywords
Normal Range
≥1.1 g/dL (portal hypertension)
| Classification | Range |
|---|---|
Portal hypertension | ≥1.1 g/dL |
Non-portal hypertension | <1.1 g/dL |
Calculates the Serum-Ascites Albumin Gradient (SAAG) to classify ascites as portal hypertensive (SAAG ≥1.1 g/dL) or non-portal hypertensive (SAAG <1.1 g/dL). This is the first-line diagnostic tool for ascites workup.
SAAG ≥1.1 g/dL is consistent with portal hypertension (cirrhosis, heart failure, Budd-Chiari). SAAG <1.1 g/dL suggests peritoneal carcinomatosis, tuberculosis, nephrotic syndrome, or pancreatic ascites. The gradient must be interpreted alongside ascitic fluid cell count, protein, glucose, and cytology.
SAAG is the single most reliable test for classifying ascites, replacing the older transudate/exudate classification. It correctly identifies portal hypertension with >90% accuracy and guides the subsequent diagnostic workup.
A patient with known cirrhosis presents with new-onset ascites. Serum albumin is 3.2 g/dL and ascitic fluid albumin is 1.0 g/dL.
Inputs:
SAAG = 3.2 − 1.0 = 2.2 g/dL (≥1.1 g/dL). Consistent with portal hypertension from cirrhosis.
SAAG (Serum-Ascites Albumin Gradient) is the difference between serum albumin and ascitic fluid albumin, both measured in g/dL. It is calculated as: SAAG = Serum albumin − Ascites albumin.
A SAAG ≥1.1 g/dL indicates that portal hypertension is the cause of ascites. Common causes include liver cirrhosis, congestive heart failure, and Budd-Chiari syndrome. The gradient is maintained because the elevated hydrostatic pressure in the portal system forces albumin-rich fluid into the peritoneal cavity.
A SAAG <1.1 g/dL indicates non-portal hypertensive causes of ascites, such as peritoneal carcinomatosis, tuberculosis, nephrotic syndrome, or pancreatic ascites. These conditions cause ascites through mechanisms other than elevated portal pressure.
SAAG may be unreliable in mixed ascites (e.g., cirrhosis with concurrent cancer), severe hypoalbuminemia (serum albumin <2.8 g/dL), or when serum and ascitic fluid samples are not collected simultaneously.
SAAG is superior to the traditional transudate/exudate classification (based on ascitic fluid protein) for classifying ascites. SAAG correctly classifies >90% of ascites, while the protein-based method misclassifies up to 20-30% of cases due to the confounding effect of serum albumin.
Disclaimer: This calculator is intended for educational and clinical decision support. SAAG should be interpreted with ascitic fluid analysis and clinical context. It does not replace comprehensive clinical assessment.
First-line classification of ascites into portal hypertensive vs. non-portal hypertensive causes.
Does not identify the specific cause of portal hypertension or non-portal hypertensive ascites.
Assessing liver disease severity and prognosis in patients with known cirrhosis.
Does not classify ascites; evaluates overall liver function.
Predicting short-term mortality in liver disease and prioritizing transplant listing.
Does not classify ascites; focuses on liver disease severity.